Disposition of 800000 shares by Morgan Adam of Alimera Sciences at 2.1 subject to Rule 16b-3
ALIMDelisted Stock | USD 5.54 0.01 0.18% |
About 62% of Alimera Sciences' investor base is looking to short. The analysis of current outlook of investing in Alimera Sciences suggests that many traders are alarmed regarding Alimera Sciences' prospects. Alimera Sciences' investing sentiment overview a quick insight into current market opportunities from investing in Alimera Sciences. Many technical investors use Alimera Sciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Alimera |
Filed transaction by Alimera Sciences Director, 10 Percent Owner: . Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at seekingalpha.com
Alimera Sciences Fundamental Analysis
We analyze Alimera Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alimera Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alimera Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Gross Profit
Gross Profit Comparative Analysis
Alimera Sciences is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Alimera Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alimera Sciences stock to make a market-neutral strategy. Peer analysis of Alimera Sciences could also be used in its relative valuation, which is a method of valuing Alimera Sciences by comparing valuation metrics with similar companies.
Peers
Alimera Sciences Related Equities
CPHI | China Pharma | 5.26 | ||||
DERM | Journey Medical | 4.14 | ||||
ORGO | Organogenesis Holdings | 0.77 | ||||
LFCR | Lifecore Biomedical | 1.20 | ||||
SHPH | Shuttle Pharmaceuticals | 2.30 | ||||
SXTC | China SXT | 2.44 | ||||
PTPI | Petros Pharmaceuticals | 6.90 | ||||
CYTH | Cyclo Therapeutics | 11.11 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Alimera Stock
If you are still planning to invest in Alimera Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alimera Sciences' history and understand the potential risks before investing.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |